Adenosine A1 modulators: a patent update (2008 to present)

Author： Giorgi Irene   Nieri Paola  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.9, 2013-09, pp. : 1109-1121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)

By Lamers Christina   Schubert-Zsilavecz Manfred   Merk Daniel  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 803-841

Informa Healthcare

Access to resources Recommend Favorite

Modulators of complement activation: a patent review (2008 – 2013)

By Larghi Enrique L   Kaufman Teodoro S  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 665-686

Informa Healthcare

Access to resources Recommend Favorite

Allosteric modulators for the A1 adenosine receptor

By Baraldi Pier Giovanni   Moorman Allan R   Tabrizi Mojgan Aghazadeh   Pavani MariaGiovanna   Romagnoli Romeo  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 71-79

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors: a patent review (2008 – present)

By Pohanka Miroslav  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 871-886

Informa Healthcare

Access to resources Recommend Favorite

Coumarin-based drugs: a patent review (2008 – present)

By Kontogiorgis Christos   Detsi Anastasia   Hadjipavlou-Litina Dimitra  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. : 437-454

Informa Healthcare

Access to resources Recommend Favorite